Neurobiology of rare diseases - Neurobiologia de malalties minoritàries (NEURADIS)
2021 SGR 00323
![Foto de Neurobiology of rare diseases - Neurobiologia de malalties minoritàries (NEURADIS)](/img/grupo.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (7)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2016
-
Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice
Metabolic Brain Disease, Vol. 31, Núm. 3, pp. 579-586
2011
-
Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors "in vitro"
Neurochemistry International, Vol. 59, Núm. 6, pp. 954-964
2010
-
Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease
Journal of Neuroimmunology, Vol. 229, Núm. 1-2, pp. 157-168
-
Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism
Free Radical Biology and Medicine, Vol. 49, Núm. 4, pp. 612-621
2008
-
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
Free Radical Biology and Medicine, Vol. 45, Núm. 5, pp. 667-678
2000
-
Nerve growth factor activation of the extracellular signal-regulated kinase pathway is modulated by Ca2+ and calmodulin
Molecular and Cellular Biology, Vol. 20, Núm. 6, pp. 1931-1946